ArticleBMC neurology2026
Artificial intelligence (AI)-powered diagnostic support for stroke via Telegram bot: preliminary findings.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnnually, stroke affects over 15 million people globally. Early intervention is critical in the management of stroke. However, the "golden hour" opportunity for timely intervention is often missed in underserved regions where experts in neuroimaging are scarce, with some countries having 1 per million inhabitants in comparison to high-income countries with 10 per million inhabitants. This study explores the feasibility of a lightweight AI-powered diagnostic support system for stroke deployed via a widely accessible platform (Telegram) to help clinicians in underserved settings.
methodsThis study utilized a comparative analysis of two transfer learning models (EfficientNetB0 and MobileNetV2) which were employed for training, using 6,650 publicly available, anonymized but radiologist annotated brain CT images from three classes: normal (n = 4,427), hemorrhagic stroke (n = 1,093), and ischemic stroke (n = 1,130). An 80/20 split was executed at slice-level as a result of lack of patient identifiers which this study acknowledges as a limitation. A separately sourced Kaggle dataset with labels but no metadata on annotator provenance was used for quasi-external validation with further evaluation using standard performance metrics. The selected model was integrated into a Telegram bot (@BrainfloBot) with real-time inference capabilities, and automatic data deletion to ensure privacy compliance.
resultsEfficientNetB0 demonstrated superior performance over MobileNetV2, achieving 99% accuracy (95% Cl: 98.2-99.5%) with excellent inter-rater reliability (κ = 0.985) during training and internal validation with precision and recall values exceeding 96% across all classes. While quasi-external validation using the balanced set, the selected model achieved a robust performance with 95% accuracy level (95% CI: 90.3%-97.9%, n = 150) with excellent agreement (κ = 0.925). For the unbalanced set, 97% accuracy level (95% Cl: 95.77%-98.03%) with excellent agreement(κ = 0.948) The model showed particularly strong performance in hemorrhagic stroke detection (98% precision, 96% recall), critical for preventing inappropriate thrombolytic therapy.
conclusionsThese preliminary findings demonstrates a successful integration of a novel AI-powered stroke diagnostics with a widely accessible messaging platform. This system can potentially close neuroimaging gaps in underserved regions where neuroimaging specialists are scarce. However, the study limitations include lack of patient-level separation, annotation provenance for external validation dataset, possible selection bias and lack of real world testing. Future work can integrate real world validation, out of distribution handling and robust testing with clinical images.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.